FEASIBILITY OF FREE-BREATHING QUANTITATIVE MYOCARDIAL PERFUSION USING MULTI-ECHO DIXON MAGNETIC RESONANCE IMAGING

Feasibility of free-breathing quantitative myocardial perfusion using multi-echo Dixon magnetic resonance imaging

Abstract Dynamic contrast-enhanced quantitative first-pass perfusion using magnetic resonance imaging enables non-invasive objective assessment of myocardial ischemia without ionizing radiation.However, quantification Clutch Pawl of perfusion is challenging due to the non-linearity between the magnetic resonance signal intensity and contrast agent

read more

Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trial.

Metastatic carcinoma of unknown primary (CUP) has a very poor prognosis, and no standard first-line therapy currently exists.Here, we report the results of a phase II study utilizing a combination of gemcitabine and irinotecan as first-line therapy.Treatment was with gemcitabine 1000 mg/m(2) and irinotecan 75 mg/m(2) weekly Balm times four on a six

read more


Critical research gaps in treating growth faltering in infants under 6 months: A systematic review and meta-analysis.

In 2020, 149.2 million children worldwide under 5 years suffered from stunting, and 45.4 million experienced wasting.Many infants are born already stunted, while others are at high risk for growth faltering early after birth.Growth faltering is linked to transgenerational impacts of poverty and marginalization.Few interventions address growth falte

read more